Copyright: ©Author(s) 2026.
World J Diabetes. Apr 15, 2026; 17(4): 119227
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.119227
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.119227
Figure 1 Pathological changes in the kidneys are improved following Jianpi Gushen Huayu Decoction administration.
A: Hematoxylin and eosin staining; B: Kidney damage score; C: Periodic acid Schiff staining; D: Glomerulosclerosis index. Magnification, × 100. bP < 0.01 as compared to the control group; cP < 0.05 as compared to the model group; dP < 0.01 as compared to the model group. JPGSL: Low-dose Jianpi Gushen Huayu Decoction; JPGSM: Medium-dose Jianpi Gushen Huayu Decoction; JPGSH: High-dose Jianpi Gushen Huayu Decoction; IRBE: Irbesartan.
- Citation: Lv SQ. Correction to “Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways”. World J Diabetes 2026; 17(4): 119227
- URL: https://www.wjgnet.com/1948-9358/full/v17/i4/119227.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i4.119227
